Parkside Financial Bank & Trust’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10
Closed -$511 2773
2024
Q4
$511 Hold
10
﹤0.01% 1870
2024
Q3
$413 Hold
10
﹤0.01% 1868
2024
Q2
$482 Buy
+10
New +$443 ﹤0.01% 1782
2024
Q1
Sell
-357
Closed -$23.2K 2108
2023
Q4
$23.2K Buy
357
+106
+42% +$6.38K ﹤0.01% 940
2023
Q3
$16.4K Buy
+251
New +$15.8K ﹤0.01% 970
2022
Q3
Sell
-235
Closed -$16K 1982
2022
Q2
$16K Sell
235
-41
-15% -$2.95K ﹤0.01% 891
2022
Q1
$25K Buy
+276
New +$22.6K 0.01% 774

Other funds holding NARI

Parkside Financial Bank & Trust's NARI Position: Q1 2025 in Review

Parkside Financial Bank & Trust sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 10 shares — an estimated $511 sold.

Parkside Financial Bank & Trust first reported a position in NARI in Q1 2022 and held it in 7 quarters. The position peaked at $25K in Q1 2022. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Parkside Financial Bank & Trust reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 10 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $511.
  • Parkside Financial Bank & Trust first reported a position in Inari Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Parkside Financial Bank & Trust's Inari Medical, Inc. Common Stock position peaked at $25K in Q1 2022.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2025, filed 8 May 2025.